menopausal Tagged Articles
Wyeth developing another HRT for menopause
Drug maker Wyeth has developed and is actively testing a new drug to treat menopause. The drug, named Aprela, has shown favorable results in the initial studies. Current evidence gathered in the study suggests that the drug may pose fewer
Hormone therapy update
According to the World Health Organization, breast cancer is the most common cancer worldwide among women. It is the fifth most deadly cancer, killing about 502,000 people per year. All of us know a family who has had to deal
Prempro user claims drug caused breast cancer
A St. Clair County woman claims her use of hormone replacement therapy drugs caused her to develop breast cancer. Minnie Louise Gray and her husband John E. Gray filed an 11-count lawsuit against Wyeth, Inc. over its drug Prempro, which
Prempro user claims drug caused breast cancer
A St. Clair County woman claims her use of hormone replacement therapy drugs caused her to develop breast cancer. Minnie Louise Gray and her husband John E. Gray filed an 11-count suit against Wyeth, Inc. over its drug Prempro, which
Natural menopause
Oestrogen and progesterone are necessary hormones for reproduction which are produced naturally by a woman’s ovaries. At around the age of 50 the body slows down and eventually stops production of these hormones, which brings on the menopause or ‘change
Wyeth must pay $134.1 million in menopause drug lawsuit
Wyeth must pay $134.1 million, including $99 million in punitive damages, over its mishandling of menopause drugs that helped cause three Nevada women’s cancers, a jury ruled.
Jury awards 3 women $134.5 million in hormone therapy lawsuit
Reno, Nev., (AP) – A jury has levied a $134.5 million judgment against the pharmaceutical maker Wyeth in a lawsuit filed by three Nevada women who contended that the company’s hormone-replacement drugs had caused their breast cancer.
Prempro lawsuit goes to the jury
After four weeks of testimony and a full day of closing arguments, jurors will begin deliberating this morning to decide whether pharmaceutical giant Wyeth is responsible for the breast cancer suffered by three Northern Nevada women who took the company’s
HRT sales rep whistleblower admits improper promotion
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week. The Nevada plaintiffs are suing Wyeth, the manufacturer of Prempro and Premarin, after they each developed breast cancer attributed
